OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators
Isabelle Fajac, Isabelle Sermet‐Gaudelus
Current Opinion in Pulmonary Medicine (2021) Vol. 27, Iss. 6, pp. 567-574
Closed Access | Times Cited: 6
Isabelle Fajac, Isabelle Sermet‐Gaudelus
Current Opinion in Pulmonary Medicine (2021) Vol. 27, Iss. 6, pp. 567-574
Closed Access | Times Cited: 6
Showing 6 citing articles:
Future therapies for cystic fibrosis
Lucy Allen, Lorna Allen, S.B. Carr, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 77
Lucy Allen, Lorna Allen, S.B. Carr, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 77
Cystic Fibrosis Modulator Therapies
Shijing Jia, Jennifer L. Taylor‐Cousar
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 413-426
Open Access | Times Cited: 53
Shijing Jia, Jennifer L. Taylor‐Cousar
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 413-426
Open Access | Times Cited: 53
Current state of CFTR modulators for treatment of Cystic Fibrosis
Katherine A. Despotes, Scott H. Donaldson
Current Opinion in Pharmacology (2022) Vol. 65, pp. 102239-102239
Open Access | Times Cited: 31
Katherine A. Despotes, Scott H. Donaldson
Current Opinion in Pharmacology (2022) Vol. 65, pp. 102239-102239
Open Access | Times Cited: 31
Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapy
Kamyron Jordan, Edith T. Zemanick, Jennifer L. Taylor‐Cousar, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 2, pp. 97-108
Closed Access | Times Cited: 9
Kamyron Jordan, Edith T. Zemanick, Jennifer L. Taylor‐Cousar, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 2, pp. 97-108
Closed Access | Times Cited: 9
Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis
Akshay Parihar, Bhupendra G. Prajapati, Himanshu Paliwal, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103729-103729
Open Access | Times Cited: 9
Akshay Parihar, Bhupendra G. Prajapati, Himanshu Paliwal, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103729-103729
Open Access | Times Cited: 9
CFTR limits F‐actin formation and promotes morphological alignment with flow in human lung microvascular endothelial cells
Adam J. Causer, Maha Khalaf, Emily Klein Rot, et al.
Physiological Reports (2021) Vol. 9, Iss. 23
Open Access | Times Cited: 5
Adam J. Causer, Maha Khalaf, Emily Klein Rot, et al.
Physiological Reports (2021) Vol. 9, Iss. 23
Open Access | Times Cited: 5
